{
  "name": "CapsoVision, Inc",
  "legal_name": "CapsoVision, Inc",
  "ticker": "CV",
  "tickers": [
    "CV"
  ],
  "cik": "0001378325",
  "page_url": "https://steadybase.io/company/capsovision-inc/",
  "markdown_url": "https://steadybase.io/company/capsovision-inc.md",
  "json_url": "https://steadybase.io/company/capsovision-inc.json",
  "as_of": "2026-11-10",
  "last_filed": "2026-08-13",
  "industry": {
    "sic": "3845",
    "description": "Electromedical & Electrotherapeutic Apparatus"
  },
  "headquarters": {
    "city": "Saratoga",
    "state": "CA",
    "country": "US"
  },
  "exchanges": [
    "Nasdaq"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "<br>Emerging growth company",
  "state_of_incorporation": "DE",
  "website": "capsovision.com",
  "investor_relations_url": "https://investors.capsovision.com/",
  "linkedin_company_url": "https://www.linkedin.com/company/capsovision-inc-",
  "summary": {
    "text": "We are a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. We develop advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care. We are a Delaware company, incorporated in 2005. Our corporate headquarters is located in Saratoga, California.",
    "section": "Item 1. Business",
    "period_end": "2025-12-31",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
  },
  "key_facts": [
    {
      "key": "revenue",
      "label": "Revenue",
      "value": 13554000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html",
      "text": "Revenue: $13.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 26, 2026)."
    },
    {
      "key": "operating_income",
      "label": "Operating income",
      "value": -25516000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html",
      "text": "Operating income: -$25.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 26, 2026)."
    },
    {
      "key": "net_income",
      "label": "Net income",
      "value": -25315000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html",
      "text": "Net income: -$25.3M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 26, 2026)."
    },
    {
      "key": "sga",
      "label": "SG&A",
      "value": 14379000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "derived",
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html",
      "text": "SG&A: $14.4M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 26, 2026)."
    },
    {
      "key": "employees",
      "label": "Employees",
      "value": 99,
      "unit": "people",
      "period_end": "2025-12-31",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm",
      "text": "Employees: 99 as of Dec 31, 2025, as reported in an SEC filing."
    },
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 50046913,
      "unit": "shares",
      "period_end": "2026-08-12",
      "form": "10-Q",
      "filed": "2026-08-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000036/0001378325-26-000036-index.html",
      "text": "Shares outstanding: 50,046,913 as of Aug 12, 2026 (10-Q filed Aug 13, 2026)."
    },
    {
      "key": "auditor",
      "label": "Auditor",
      "value": "Baker Tilly Us, LLP",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm",
      "text": "Auditor: Baker Tilly Us, LLP, Santa Clara, California, named in the latest 10-K."
    }
  ],
  "metrics": {
    "revenue": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 13554000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 11756000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      }
    ],
    "operating_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": -25516000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": -19917000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      }
    ],
    "net_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": -25315000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": -19898000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      }
    ],
    "sga": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 14379000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 11174000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2026-03-26",
        "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.html"
      }
    ]
  },
  "next_earnings": {
    "date": "2026-11-12",
    "confidence": "medium",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Kang-Huai (Johnny) Wang",
      "title": "Director, President and Chief Executive Officer (Principal Executive Officer)",
      "role": "both",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "David Garcia",
      "title": "Senior VP of Finance (Principal Financial Officer and Principal Accounting Officer)",
      "role": "officer",
      "linkedin_url": "https://www.linkedin.com/in/david-garcia-li",
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "Chen Lung Tsai",
      "title": "Chairman of the Board of Directors",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "David Michael Garcia",
      "title": "Sr. VP of Finance",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-06-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000209311226000002/0002093112-26-000002-index.htm"
    },
    {
      "name": "Douglas Patrick Atkinson",
      "title": "Head of Global Sales",
      "role": "officer",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-06-03",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000207410526000004/0002074105-26-000004-index.htm"
    },
    {
      "name": "Hui Ying (Patty) Kuo",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "Joanne Imperial, M.D.",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "Julia Gouw",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "Keri Jorgenson",
      "title": "Director of Clinical Operations",
      "role": "officer",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "Michele Harari",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "name": "Wen-Herng (Henry) King",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-09-28",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000045/cv-20260925.htm"
    },
    {
      "filed": "2026-09-18",
      "items": [
        {
          "item": "1.01",
          "label": "Entry into a material definitive agreement",
          "signal": "deal"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000043/cv-20260917.htm"
    },
    {
      "filed": "2026-08-18",
      "items": [
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000039/cv-20260813.htm"
    },
    {
      "filed": "2026-08-13",
      "items": [
        {
          "item": "1.01",
          "label": "Entry into a material definitive agreement",
          "signal": "deal"
        },
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000035/cv-20260813.htm"
    },
    {
      "filed": "2026-07-02",
      "items": [
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/cv-20260701.htm"
    },
    {
      "filed": "2026-06-12",
      "items": [
        {
          "item": "5.07",
          "label": "Submission of matters to a vote of security holders",
          "signal": "governance"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000023/cv-20260611.htm"
    },
    {
      "filed": "2026-05-14",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000019/cv-20260514.htm"
    },
    {
      "filed": "2026-03-26",
      "items": [
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000008/cv-20260326.htm"
    },
    {
      "filed": "2026-03-20",
      "items": [
        {
          "item": "1.01",
          "label": "Entry into a material definitive agreement",
          "signal": "deal"
        },
        {
          "item": "2.02",
          "label": "Results of operations and financial condition (earnings release)",
          "signal": "earnings"
        },
        {
          "item": "3.02",
          "label": "Unregistered sales of equity securities",
          "signal": "financing"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000004/cv-20260320.htm"
    },
    {
      "filed": "2026-03-13",
      "items": [
        {
          "item": "1.01",
          "label": "Entry into a material definitive agreement",
          "signal": "deal"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000002/cv-20260313.htm"
    }
  ],
  "insider_trades": [],
  "quotes": [
    {
      "text": "The second quarter marked another important step in the evolution of CapsoVision as we advanced both our commercial execution and product innovation. We were pleased to launch AI Highlights™ internationally, providing physicians in Europe with an AI-assisted workflow solution that complements our CapsoCam Plus® platform and reinforces our long-term vision of integrated, AI-enabled capsule endoscopy",
      "speaker": "Johnny Wang",
      "title": "President and Chief Executive Officer of CapsoVision",
      "form": "8-K",
      "filed": "2026-08-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000035/cv-20260813xex991q22026ear.htm"
    }
  ],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-09-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000045/cv-20260925.htm"
    },
    {
      "form": "10-K",
      "filed": "2026-03-26",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/cv-20251231.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-08-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000036/cv-20260630.htm"
    },
    {
      "form": "DEF 14A",
      "filed": "2026-04-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/1378325/000137832526000013/cv-20260427.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}